TARDBP and amyotrophic lateral sclerosis: For example, studies on amyotrophic lateral sclerosis (ALS) have demonstrated that overexpression of mutant TDP-43 in OLs leads to oligodendrocyte damage and motor dysfunction, accompanied by downregulation of cognition-related oligodendrocyte marker genes and cholesterol-associated genes.